0.8996USD+116.77%Mkt Cap: 13.10M USDP/E: —Last update: 2026-06-01
AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap13.10M USD
Enterprise Value3.91M USD
Revenue (TTM)88.00K USD
Gross Profit-40.00K USD
Net Income (TTM)-13.96M USD
Revenue/Share0.0540 USD
Last Price0.8996 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees19
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS00901B1052
Valuation
P/E (Trailing)—
P/E (Forward)-0.28
PEG0.71
EV/EBITDA-0.34
EV/Revenue44.44
P/S67.49
P/B-0.13
EPS (TTM)-4.31
EPS (Forward)-1.47
52W Range
0.21004% of range19.74
52W High19.74 USD
52W Low0.2100 USD
Profitability
Gross Margin-45.45%
Oper. Margin-14057.14%
EBITDA Margin0.00%
Profit Margin-15861.36%
ROE142.68%
ROA-241.40%
Growth
Revenue Growth-53.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.96M USD
CapEx (TTM)378.00K USD
FCF Margin-13598.30%
FCF Yield-91.34%
Net Debt1.85M USD
Net Debt/EBITDA-0.16
Balance Sheet
Debt/Equity-0.50
Current Ratio0.53
Quick Ratio0.49
Book Value/Sh-3.1870 USD
Cash/Share0.3740 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1031:1000
Split DateFeb 10, 2026
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)5.750 USD
Target Range1.500 USD – 10.00 USD
# Analysts2
Ownership
Shares Out.14.56M
Float7.99M
Insiders1.98%
Institutions2.48%
Short Interest
Short Ratio1.0d
Short % Float3.79%
Short % Out.3.72%
Shares Short303.17K
Short (prev mo.)159.72K
Technical
SMA 500.5286 (+70.2%)
SMA 2001.410 (-36.2%)
Beta1.24
S&P 52W Chg27.94%
Avg Vol (30d)48.90M
Avg Vol (10d)109.77M
Technical Indicators
RSI (14)50.6
MACD-0.0467
MACD Signal-0.0682
MACD Hist.+0.0215
BB Upper0.5948 USD
BB Middle0.3687 USD
BB Lower0.1426 USD
BB Width122.65%
ATR (14)0.1073 USD
Vol Ratio (20d)0.21x